BioCardia Inc
For the period ended Dec 31, 2023. Filed Mar 27, 2024.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2023 · Filed Mar 27, 2024
BCDA$0.93+3.1%Stored close · as of Nov 10, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Consolidated Statements of Stockholders’ Equity (Deficit)
BIOCARDIA, INC.
Consolidated Statements of Stockholders’ Equity (Deficit)
For the Years Ended December 31, 2023 and 2022
(In thousands, except share data)
| Common stock · Additional · Accumulated | |||||
|---|---|---|---|---|---|
| Shares | Cost | paid-in capital | deficit | Total | |
| Balance at December 31, 2021 | 16,871,265 | $17 | $139,055 | $(128,697) | $10,375 |
| Restricted stock units vested and issued | 371,980 | — | — | — | — |
| Sale of common stock under ATM, net of issuance costs of $256 | 711,511 | 1 | 1,546 | — | 1,547 |
| Sale of common stock on December 14, 2022, net of issuance costs of $162 | 2,122,017 | 2 | 3,401 | — | 3,403 |
| Restricted stock units issued to settle management bonus obligations | — | — | 291 | — | 291 |
| Share-based compensation | — | — | 1,183 | — | 1,183 |
| Net loss | — | — | — | (11,907) | (11,907) |
| Balance at December 31, 2022 | 20,076,773 | $20 | $145,476 | $(140,604) | $4,892 |
| Restricted stock units vested and issued | 241,197 | 1 | — | — | 1 |
| Sale of common stock under ATM, net of issuance costs of $179 | 215,224 | — | 262 | — | 262 |
| Sale of common stock on June 21, 2023, net of issuance costs of $194 | 1,133,141 | 1 | 2,452 | — | 2,453 |
| Sale of common stock on November 16, 2023, net of issuance costs of $312 | 2,000,000 | 2 | 986 | — | 988 |
| Restricted stock units issued to settle management bonus obligations | — | — | 342 | — | 342 |
| Exercise of common stock options | 199 | — | — | — | — |
| Share-based compensation | — | — | 1,030 | — | 1,030 |
| Net loss | — | — | — | (11,571) | (11,571) |
| Balance at December 31, 2023 | 23,666,534 | $24 | $150,548 | $(152,175) | $(1,603) |
See accompanying notes to consolidated financial statements.
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.